Paying users zone. Data is hidden behind: .
Get 1-month access to Becton, Dickinson & Co. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Price to FCFE (P/FCFE)
Intermediate level
Free Cash Flow to Equity (FCFE)
Becton, Dickinson & Co., FCFE calculation
US$ in millions
Based on: 10-K (filing date: 2019-11-27), 10-K (filing date: 2018-11-21), 10-K (filing date: 2017-11-22), 10-K (filing date: 2016-11-23), 10-K (filing date: 2015-11-25), 10-K (filing date: 2014-11-26).
| Item | Description | The company |
|---|---|---|
| FCFE | Free cash flow to equity is the cash flow available to Becton, Dickinson & Co.’s equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made. | Becton, Dickinson & Co.’s FCFE decreased from 2017 to 2018 and from 2018 to 2019. |
Price to FCFE Ratio, Current
Becton, Dickinson & Co., current P/FCFE calculation, comparison to benchmarks
| No. shares of common stock outstanding | |
| Selected Financial Data (US$) | |
| Free cash flow to equity (FCFE) (in millions) | |
| FCFE per share | |
| Current share price (P) | |
| Valuation Ratio | |
| P/FCFE | |
| Benchmarks | |
| P/FCFE, Competitors1 | |
| Boston Scientific Corp. | |
| Danaher Corp. | |
| Intuitive Surgical Inc. | |
| Medtronic PLC | |
| Stryker Corp. | |
| Thermo Fisher Scientific Inc. | |
| UnitedHealth Group Inc. | |
| P/FCFE, Sector | |
| Health Care Equipment & Services | |
| P/FCFE, Industry | |
| Health Care | |
Based on: 10-K (filing date: 2019-11-27).
1 Click competitor name to see calculations.
If the company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if the company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.
Price to FCFE Ratio, Historical
Becton, Dickinson & Co., historical P/FCFE calculation, comparison to benchmarks
| Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | ||
|---|---|---|---|---|---|---|---|
| No. shares of common stock outstanding1 | |||||||
| Selected Financial Data (US$) | |||||||
| Free cash flow to equity (FCFE) (in millions)2 | |||||||
| FCFE per share3 | |||||||
| Share price1, 4 | |||||||
| Valuation Ratio | |||||||
| P/FCFE5 | |||||||
| Benchmarks | |||||||
| P/FCFE, Competitors6 | |||||||
| Boston Scientific Corp. | |||||||
| Danaher Corp. | |||||||
| Intuitive Surgical Inc. | |||||||
| Medtronic PLC | |||||||
| Stryker Corp. | |||||||
| Thermo Fisher Scientific Inc. | |||||||
| UnitedHealth Group Inc. | |||||||
| P/FCFE, Sector | |||||||
| Health Care Equipment & Services | |||||||
| P/FCFE, Industry | |||||||
| Health Care | |||||||
Based on: 10-K (filing date: 2019-11-27), 10-K (filing date: 2018-11-21), 10-K (filing date: 2017-11-22), 10-K (filing date: 2016-11-23), 10-K (filing date: 2015-11-25), 10-K (filing date: 2014-11-26).
1 Data adjusted for splits and stock dividends.
3 2019 Calculation
FCFE per share = FCFE ÷ No. shares of common stock outstanding
= ÷ =
4 Closing price as at the filing date of Becton, Dickinson & Co.’s Annual Report.
5 2019 Calculation
P/FCFE = Share price ÷ FCFE per share
= ÷ =
6 Click competitor name to see calculations.
| Valuation ratio | Description | The company |
|---|---|---|
| P/FCFE | Price to free cash flow to equity is cash valuation indicator of stockholders’ equity. | Becton, Dickinson & Co.’s P/FCFE ratio increased from 2017 to 2018 and from 2018 to 2019. |